trastuzumab,pertuzumab
roche
[]
phergain s remarkable success rates in preventing cancer recurrence and the high cancer-free rate after three years offer hope for improved patient care and quality of life. these results were presented by at #asco23! click the link to learn more! #phergain
Bring your idea to life💡Creating successful IITs & optimal drug development📊Medica Scientia Innovation Research🇪🇸🇺🇸https://t.co/TnOtdKHgxy…